HK1028251A1 - Oligosaccharide mixtures having antithrombotic activity - Google Patents

Oligosaccharide mixtures having antithrombotic activity

Info

Publication number
HK1028251A1
HK1028251A1 HK00107173A HK00107173A HK1028251A1 HK 1028251 A1 HK1028251 A1 HK 1028251A1 HK 00107173 A HK00107173 A HK 00107173A HK 00107173 A HK00107173 A HK 00107173A HK 1028251 A1 HK1028251 A1 HK 1028251A1
Authority
HK
Hong Kong
Prior art keywords
mixture
weight
content
sulphate
disaccharide
Prior art date
Application number
HK00107173A
Other languages
English (en)
Inventor
Mons Lundqvist
Kristian Betton Johansen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10813494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1028251(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of HK1028251A1 publication Critical patent/HK1028251A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
HK00107173A 1997-06-03 2000-11-10 Oligosaccharide mixtures having antithrombotic activity HK1028251A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711443.3A GB9711443D0 (en) 1997-06-03 1997-06-03 Chemical suppositions
PCT/EP1998/003007 WO1998055514A1 (en) 1997-06-03 1998-05-15 Oligosaccharide mixtures having antithrombotic activity

Publications (1)

Publication Number Publication Date
HK1028251A1 true HK1028251A1 (en) 2001-02-09

Family

ID=10813494

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107173A HK1028251A1 (en) 1997-06-03 2000-11-10 Oligosaccharide mixtures having antithrombotic activity

Country Status (20)

Country Link
US (1) US6486137B1 (hu)
EP (1) EP0986580B1 (hu)
JP (1) JP2002502454A (hu)
KR (1) KR20010013284A (hu)
CN (1) CN1145643C (hu)
AT (1) ATE236933T1 (hu)
AU (1) AU740671B2 (hu)
CA (1) CA2293587A1 (hu)
CZ (1) CZ292622B6 (hu)
DE (1) DE69813216T2 (hu)
DK (1) DK0986580T3 (hu)
ES (1) ES2193534T3 (hu)
GB (1) GB9711443D0 (hu)
HK (1) HK1028251A1 (hu)
HU (1) HUP0002333A3 (hu)
NZ (1) NZ501254A (hu)
PL (1) PL337231A1 (hu)
PT (1) PT986580E (hu)
RU (1) RU2216548C2 (hu)
WO (1) WO1998055514A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440445B1 (en) 1996-09-30 2002-08-27 Brigham & Women's Hospital Methods and compounds for treatment of abnormal uterine bleeding
WO2003018032A1 (en) * 2001-08-28 2003-03-06 Leo Pharma A/S Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
CN100345868C (zh) * 2003-04-18 2007-10-31 山东大学 一种低分子硫酸皮肤素及其制备方法
US20070219161A1 (en) * 2004-03-26 2007-09-20 Junichi Tamura Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
SG191613A1 (en) * 2008-05-30 2013-07-31 Momenta Pharmaceuticals Inc Saccharide structures and methods of making and using such structures
ES2364683B1 (es) * 2009-12-29 2012-08-08 Bioibérica S.A. Disacáridos sulfatados para el tratamiento de enfermedades neurodegenerativas y/o neurovasculares.
WO2013006906A1 (en) * 2011-07-11 2013-01-17 Commonwealth Scientific And Industrial Research Organisation Dermatan sulphate, pharmaceutical compositions and process for producing same
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
ME02994B (me) 2011-12-19 2018-10-20 Dilafor Ab Glikozaminoglikani koji nisu anтikoagulanтi koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba
CN103160486A (zh) * 2013-04-02 2013-06-19 黑龙江迪龙制药有限公司 一种猪凝血酶的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230582B (it) * 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
IT1251183B (it) * 1991-08-28 1995-05-04 Opocrin Spa Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.
IT1251182B (it) * 1991-08-28 1995-05-04 Opocrin Spa Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche.
US5922690A (en) * 1996-04-25 1999-07-13 Van Gorp; Cornelius L. Dermatan disulfate, an inhibitor of thrombin generation and activation

Also Published As

Publication number Publication date
EP0986580B1 (en) 2003-04-09
NZ501254A (en) 2001-12-21
CZ431699A3 (cs) 2000-04-12
PT986580E (pt) 2003-08-29
ATE236933T1 (de) 2003-04-15
DK0986580T3 (da) 2003-08-04
PL337231A1 (en) 2000-08-14
DE69813216T2 (de) 2004-01-29
CN1145643C (zh) 2004-04-14
WO1998055514A1 (en) 1998-12-10
ES2193534T3 (es) 2003-11-01
AU7914698A (en) 1998-12-21
GB9711443D0 (en) 1997-07-30
JP2002502454A (ja) 2002-01-22
KR20010013284A (ko) 2001-02-26
RU2216548C2 (ru) 2003-11-20
DE69813216D1 (de) 2003-05-15
HUP0002333A2 (hu) 2000-12-28
US6486137B1 (en) 2002-11-26
EP0986580A1 (en) 2000-03-22
AU740671B2 (en) 2001-11-08
CZ292622B6 (cs) 2003-11-12
CN1259143A (zh) 2000-07-05
HUP0002333A3 (en) 2002-01-28
CA2293587A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
HK1028251A1 (en) Oligosaccharide mixtures having antithrombotic activity
IT1271057B (it) Polisaccaridi aventi un elevato contenuto di acido iduronico
Greenwald et al. Degradation of hyaluronic acid by polymorphonuclear leukocytes
ES2021905A6 (es) Procedimiento para la preparacion de fracciones de sulfato de dermatano.
ECSP055722A (es) Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
CA2007616A1 (en) Heparinic derivatives and process for their preparation
CA2279535A1 (en) Dermatan disulfate, an inhibitor of thrombin generation and complement activation
Fransson et al. Interaction between dermatan sulphate chains II. Structural studies on aggregating glycan chains and oligosaccharides with affinity for dermatan sulphate-substituted agarose
Choay Biologic studies on chemically synthesized pentasaccharide and tetrasaccharide fragments
Fransson et al. The copolymeric structure of pig skin dermatan sulphate. Isolation and characterization of L-idurono-sulphate-containing oligosaccharides from copolymeric chains
AU571349B2 (en) Membrane polysaccharides
Cöster et al. The co-polymeric structure of pig skin dermatan sulphate. Distribution of L-iduronic acid sulphate residues in co-polymeric chains
AU637143B2 (en) Sulphated glycosaminoglycuronan with antithrombotic activity
ES8802470A1 (es) Un procedimiento para la preparacion de un nuevo agente antitrombosico a base de una mezcla de glicosaminoglicanos.
AU5833694A (en) Oligosaccharides having biological activity and preparation of same from glycosaminoglycans
Casu Structure, shape and function of glycosaminoglycans
THOMAS ANTICOAGULANT ACTIONS OF SULPHATED POLYSACCHARIDES TW BARROWCLIFFE, R EMERTON, J WATTON, E GRAY
Endo et al. Terminal monosaccharides of carbohydrate chains of glycosaminoglycans in normal human urine

Legal Events

Date Code Title Description
PF Patent in force